ORMP
Oramed Pharmaceuticals Inc.
Biotechnology · Healthcare · United States
4.11
close · 2026-10-30
value
92
cheaper than peers92
quality
97
stronger fundamentals97
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 2 years ago | 3.4% | 100 |
| earnings yield, latest year | 36.5% | 100 |
| price to book | 0.53× | 92 |
| cash flow yield, latest year | -6.5% | 76 |
| cash flow yield, 1 year ago | -4.9% | 74 |
| earnings yield, 1 year ago | -11.7% | 69 |
| cash flow yield, 2 years ago | -6.2% | 65 |
| earnings yield, 3 years ago | -22.9% | 62 |
| cash flow yield, 3 years ago | -16.6% | 47 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 74.2% | 100 |
| debt to equity | 0.2% | 92 |
| operating margin | 0.0% | 50 |
3 of 4 measures available
Facts
| market cap | $171M |
| free cash flow | $2.5M |
| employees | none reported |
| first trade | 2007-05-01 |
| next earnings | 2026-08-10 |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 1.50 | -0.48 | 0.14 | -0.94 |
| free cash flow | -$11.1M | -$8.4M | -$10.5M | -$28.4M |
| net income | $64.0M | -$19.1M | $5.5M | -$36.6M |
| revenue | $2.0M | $0 | $1.3M | $2.7M |
| unusual items | $87.7M | -$7.2M | $16.3M | -$630,000 |